Ribociclib approved as the first-line agent for metastatic breast cancer
Breast cancer is the second leading cause of cancer-related mortality in women, after lung cancer.1 The American Cancer Society...
Breast cancer is the second leading cause of cancer-related mortality in women, after lung cancer.1 The American Cancer Society...
Ovarian cancer is the 7th most commonly diagnosed cancer in women worldwide1 and the 5th most common cause of...
The US FDA approved the use of Rydapt (midostaurin) in combination with chemotherapy for treating recently diagnosed adults with...
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is not breast cancer but a rare type of T-cell lymphoma that...
Skin cancer is common; however, Merkel cell carcinoma (MCC) is a rare type of aggressive skin cancer that affects...
Adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer who have responded completely or partially to...
Soft-tissue sarcomas (STS) are an uncommon and diverse group of malignancies originating from mesenchymal precursors that are responsible for...
Human beings are the most evolved organisms on the planet. Many of their tissues can continuously renew throughout life,...
For women undergoing hysterectomy, it is a norm that her ovaries are also removed as a prophylactic measure because...
Glioblastoma, an aggressive type of incurable brain cancer may have found a ray of hope with this groundbreaking study...